Featured Video Play Icon

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

InvestorIntel Interviews Dr. Zerbe of IntelGenx on Cialis deal

In this InvestorIntel interview, Dr. Horst G. Zerbe, President and CEO of IntelGenx Technologies Corp. (TSXV: IGX |OTCQX: IGXT), discusses the recent deal with Eli Lilly to manufacture Tadalafil (also known as Cialis®) as a pharmaceutical oral film, using IntelGenx’s VersaFilm™ technology. IntelGenx’s tadalafil oral film offers an improved discrete dosage form that does not require water intake. Dr. Zerbe states that this deal is significant because moving forward potential partner licensees will not face any litigation after completing a deal with IntelGenx, making the launch and commercialization of a VersaFilm™ partnered product extremely easy.

 

Major Aerospace Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )